Dental treatment and risk of variant CJD - a case control study

被引:10
作者
Everington, D.
Smith, A. J.
Ward, H. J. T.
Letters, S.
Will, R. G.
Bagg, J.
机构
[1] Univ Glasgow, Sch Dent, Infect Res Grp, Glasgow G2 3JZ, Lanark, Scotland
[2] Univ Edinburgh, Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
10.1038/bdj.2007.126
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective Knowledge of risk factors for variant CJD (vCJD) remains limited, but transmission of prion proteins via re-useable medical devices, including dental instruments, or enhanced susceptibility following trauma to the oral cavity is a concern. This study aimed to identify whether previous dental treatment is a risk factor for development of vCJD. Design Case control study. Methods Risk factor questionnaires completed by interview with relatives of 130 vCJD patients and with relatives of 66 community and 53 hospital controls were examined by a dental surgeon. Responses regarding dental treatments were analysed. Results We did not find a statistically significant excess of risk of vCJD associated with dental treatments with the exception of extractions in an unmatched analysis of vCJD cases with community controls ( p = 0.02). However, this result may be explained by multiple testing. Conclusions This is the first published study to date to examine potential links between vCJD and dental treatment. There was no convincing evidence found of an increased risk of variant CJD associated with reported dental treatment. However, the power of the study is restricted by the number of vCJD cases to date and does not preclude the possibility that some cases have resulted from secondary transmission via dental procedures. Due to the limitations of the data available, more detailed analyses of dental records are required to fully exclude the possibility of transmission via dental treatment.
引用
收藏
页码:E19 / E19
页数:3
相关论文
共 18 条
[1]   Rapid prion neuroinvasion following tongue infection [J].
Bartz, JC ;
Kincaid, AE ;
Bessen, RA .
JOURNAL OF VIROLOGY, 2003, 77 (01) :583-591
[2]   Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease [J].
Blanquet-Grossard, F ;
Sazdovitch, V ;
Jean, A ;
Deslys, JP ;
Dormont, D ;
Hauw, JJ ;
Marion, D ;
Brown, P ;
Cesbron, JY .
JOURNAL OF DENTAL RESEARCH, 2000, 79 (02) :700-700
[3]   Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study [J].
Collins, S ;
Law, MG ;
Fletcher, A ;
Boyd, A ;
Kaldor, J ;
Masters, CL .
LANCET, 1999, 353 (9154) :693-697
[4]   CREUTZFELDT-JAKOB DISEASE - POSSIBLE MEDICAL RISK-FACTORS [J].
DAVANIPOUR, Z ;
ALTER, M ;
SOBEL, E ;
ASHER, D ;
GAJDUSEK, DC .
NEUROLOGY, 1985, 35 (10) :1483-1486
[5]  
*DEP HLTH EC OP RE, 2003, RISK ASSESSMENT VCJD
[6]   Investigation of PrPres in dental tissues in variant CJD [J].
Head, MW ;
Ritchie, D ;
McLoughlin, V ;
Ironside, JW .
BRITISH DENTAL JOURNAL, 2003, 195 (06) :339-343
[7]  
Ingrosso L, 1999, J GEN VIROL, V80, P3043, DOI 10.1099/0022-1317-80-11-3043
[8]   A CASE CONTROL STUDY OF CREUTZFELDT-JAKOB DISEASE - ASSOCIATION WITH PHYSICAL INJURIES [J].
KONDO, K ;
KUROIWA, Y .
ANNALS OF NEUROLOGY, 1982, 11 (04) :377-381
[9]   Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion [J].
Llewelyn, CA ;
Hewitt, PE ;
Knight, RSG ;
Amar, K ;
Cousens, S ;
Mackenzie, J ;
Will, RG .
LANCET, 2004, 363 (9407) :417-421
[10]   A study of blood contamination of Siqveland matrix bands [J].
Lowe, AH ;
Bagg, J ;
Burke, FJT ;
MacKenzie, D ;
McHugh, S .
BRITISH DENTAL JOURNAL, 2002, 192 (01) :43-45